Clinical trials
Terminated Phase 2 Carcinoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2005 | 1 |
| 2006 | 3 |
| 2007 | 1 |
| 2008 | 5 |
| 2009 | 2 |
| 2010 | 4 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2021 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 25 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 2 |
| Abbott | 1 |
| Amgen | 1 |
| Association of Urologic Oncology (AUO) | 1 |
| Austrian Breast & Colorectal Cancer Study Group | 1 |
| Cascadian Therapeutics Inc. | 1 |
| Cedars-Sinai Medical Center | 1 |
| Center for International Blood and Marrow Transplant Research | 1 |
| Duke University | 1 |
| HaEmek Medical Center, Israel | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma | 25 |
| Neoplasms | 6 |
| Adenocarcinoma | 5 |
| Neoplasm Metastasis | 5 |
| Carcinoma, Renal Cell | 4 |
| Neoplasms, Glandular and Epithelial | 4 |
| Neoplasms by Site | 3 |
| Carcinoma, Hepatocellular | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Carcinoma, Squamous Cell | 2 |
Trials
Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.